EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudie

Level of sedation in patients with COVID-19 supported with ECMO: A comparative analysis of the critical care consortium international database

Silver Heinsar iD, Ahmed Labib iD, Marcela Cespedes, Jordi Riera iD, Nicole White, Akram Zaaqoq iD, Jeffrey P Jacobs, Hergen Buscher iD, Peta M A Alexander, Anna Ciullo, Muhammad Aftab, Jacky Y Suen und 5 weitere

Perfusion · 2025

DOI: 10.1177/02676591251324136 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Perfusion, 2025. Verfasst von Silver Heinsar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, COVID-19, SARS-CoV-2, Critical Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: The Bill & Melinda Gates Foundation, Queensland Health, The Prince Charles Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liberation from sedation may be beneficial for patients with acute respiratory distress syndrome supported by veno-venous (VV) extracorporeal membrane oxygenation (ECMO). Currently, there is limited evidence to support this approach. Therefore, this study aimed to compare the 90-day patient mortality of different sedation strategies in COVID-19 patients supported with VV ECMO.

Methods

Retrospective, observational sub-study of the COVID-19 Critical Care Consortium database including COVID-19 patients supported with VV ECMO. Two cohorts were compared: high sedation patients who received neuromuscular blocking agents (NMBAs) throughout ECMO and low sedation patients who did not receive NMBA consistently. Patients’ level of sedation during ECMO was also considered. The primary outcome was 90-day in-hospital mortality and was assessed using cause-specific Cox proportional hazard models.

Results

224 low and 104 high sedation patients were included. Pre-ECMO respiratory condition prior was similar between groups, except for the ratio of partial pressure of oxygen to inspired fraction of oxygen, which was lower in the high sedation group at 93 [61–130] than the low sedation group at 106 [69–140]. No difference was observed in disease severity scores between cohorts. Low sedation patients had longer ECMO runs, more circuit changes, but lower infectious and hemorrhagic complications. Higher sedation was associated with a hazard ratio for death of 3.23 (95% CI 2.16–4.83) compared to low sedation.

Conclusions

Reduced sedation in COVID-19 ECMO patients is feasible and may be associated with improved survival and reduced complications compared to continuous paralysis, albeit with longer ECMO runs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracorporeal Membrane OxygenationCOVID-19SARS-CoV-2Critical CareNeuromuscular Blocking AgentsHumansFemaleMaleMiddle AgedDatabases, FactualAgedHospital MortalityAdult

Stichwörter der Autor:innen

extracorporeal membrane oxygenationsedationsevere acute respiratory syndrome-related coronavirusvenovenous extracorporeal membrane oxygenation

Substanzen

Neuromuscular Blocking Agents

Autor:innen und Institutionen

  • Critical Care Research Group, The Prince Charles Hospital, Brisbane, QLD, Australia.
  • Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
  • Department of Cardiology, North Estonia Medical Centre, Tallinn, Estonia.
  • Department of Cardiology, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
  • Department of Anesthesiology, Weill Cornell Medical College, Doha, Qatar.

ORCID-Profile: Silver Heinsar, Ahmed Labib, Jordi Riera, Akram Zaaqoq, Hergen Buscher, Roberto Lorusso, Giles Peek

Förderung

  • The Bill & Melinda Gates Foundation
  • Queensland Health
  • The Prince Charles Hospital Foundation
  • The Wesley Medical Research; Fisher & Paykel Healthcare
  • The University of Queensland
  • The Health Research Board of Ireland
  • Estonian Research Council grant
  • Advance Queensland fellowship program

Zitieren

APA

Heinsar, S., Labib, A., Cespedes, M., Riera, J., White, N., Zaaqoq, A., Jacobs, J. P., Buscher, H., Alexander, P. M. A., Ciullo, A., Aftab, M., Suen, J. Y., Bassi, G. L., Lorusso, R., Fraser, J. F., Peek, G., & COVID-19 Critical Care Consortium (COVID Critical) (2025). Level of sedation in patients with COVID-19 supported with ECMO: A comparative analysis of the critical care consortium international database. Perfusion. https://doi.org/10.1177/02676591251324136

Vancouver

Heinsar S, Labib A, Cespedes M, Riera J, White N, Zaaqoq A, et al. Level of sedation in patients with COVID-19 supported with ECMO: A comparative analysis of the critical care consortium international database. Perfusion. 2025. doi:10.1177/02676591251324136

BibTeX
@article{Heinsar2025,
  author = {Heinsar, Silver and Labib, Ahmed and Cespedes, Marcela and Riera, Jordi and White, Nicole and Zaaqoq, Akram and Jacobs, Jeffrey P and Buscher, Hergen and Alexander, Peta M A and Ciullo, Anna and Aftab, Muhammad and Suen, Jacky Y and Bassi, Gianluigi Li and Lorusso, Roberto and Fraser, John F and Peek, Giles and COVID-19 Critical Care Consortium (COVID Critical), COVID-19 Critical Care Consortium (COVID Critical)},
  title = {Level of sedation in patients with COVID-19 supported with ECMO: A comparative analysis of the critical care consortium international database},
  journal = {Perfusion},
  year = {2025},
  doi = {10.1177/02676591251324136}
}
Kostenlos starten →